WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) said it will take center stage at two major healthcare investor ...

Anaptys recently announced the intent to separate its biopharma operations from its substantial royalty assets by year-end 2026, enabling investors to align their investment philosophies and portfolio ...

Returning for its fourth year, Bisnow’s International Life Sciences & Biotech Conference returns to San Diego in 2026. As the global life sciences industry continues to drive innovation, this two-day ...

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on Thursday, February 27, 2025, following ...

The biotech industry’s largest annual conclave comes to Boston next week, and it’s a stressful time for those in the business of developing new drugs and medical treatments. Companies are declaring ...

Company management will be participating in one-on-one investor meetings at the conferences. To schedule a meeting, please submit a request on the conference website, contact your H.C. Wainwright or ...

PRINCETON, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune ...

TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...

Join us for Bisnow's New York Life Sciences Conference where top developers and city officials will discuss attracting top tenants to grow the New York life sciences ecosystem. Hear about designing ...

The 11th International Plant Tissue Culture and Biotechnology Conference concluded on Monday at the Department of Botany, University of Dhaka. The conference stared on Saturday. Organized jointly by ...

PRINCETON, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune ...